4
Changes in Ownership
Avalo Therapeutics, Inc. Filed Acc 0001677036-25-000004
Options or other derivatives
- Director acquired 40,200 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Lind Kevin Robert Director | 2025-10-01 | Grant or award · Stock Option (Right to Buy) | +40,200 | 40,200 | D: show line 1 in the form |
Loading xslF345X05/primary_doc.xml…